Advances in immunology Volume 55
From the Reviews of Previous Volumes "Provides unrivalled value in both academic and fiscal terms and should be purchased by hard pressed librarians as a major priority to be jealously defended."--JOURNAL OF MEDICAL MICROBIOLOGY "Advances in Immunology must find itself among the most...
| Other Authors: | Dixon, Frank J. 1920-2008,, ScienceDirect (Online service) |
|---|---|
| Format: | Electronic |
| Language: | English |
| Published: |
San Diego ; New York ; Boston :
Academic Press,
[1994]
|
| Physical Description: |
1 online resource (viii, 455 pages) : illustrations. |
| Series: |
Advances in immunology.
|
| Subjects: |
Table of Contents:
- Front Cover; Advances in Immunology, Volume 55; Copyright Page; Contents; Chapter 1. The kit Ligand, Stem Cell Factor; I. Introduction; II. The Stem Cell Factor Receptor, Encoded by the c-kit Gene; III. The kit Ligand, Stem Cell Factor; IV. Tissue Distribution of SCF and the SCF Receptor; V. Nature and Biological Consequences of Mutations Affecting SCF or the SCF Receptor; VI. Regulation of Expression of SCF and the SCF Receptor; VII. Signal Transduction through the SCF Receptor; VIII. Biological Consequences of Interactions between the SCF Receptor and Its Ligand; IX. Lymphohematopoiesis.
- X. Mast Cell BiologyXI. Melanocyte Biology; XII. Germ Cell Development; XIII. The Nervous System; XIV. Neoplasia; XV. SCF as a Therapeutic Agent; XVI. Concluding Remarks; References; Chapter 2. Interleukin-8 and Related Chemotactic Cytokines-CXC and CC Chemokines; I. Introduction; II. Structures and Chemical Properties; III. Chemokine Genes; IV. Cellular Sources of CXC and CC Proteins; V. Biological Activities; VI. Receptors; VII. Signal Transduction; VIII. Role in Pathology; References; Chapter 3. Receptors for Transforming Growth Factor-ß; I. Introduction.
- II. Structure and Activity of Members of the TGF-ß SuperfamilyIII. Serine/Threonine Kinase Receptors; IV. Other TGF-ß Receptors; V. Signal Transduction by TGF-ß; VI . Perspectives; References; Chapter 4. Biochemistry of B Lymphocyte Activation; I. Introduction; II. Different Models of B Cell Activation; III. Structure of the B Cell Antigen Receptor; IV. Initial Signaling Reactions Stimulated by the B Cell Antigen Receptor; V. Early Cellular Events Following Antigen Contact; VI. Mechanism of Contact-Dependent T Cell Help.
- VII. Signaling by Receptors for B Cell Growth and Differentiation FactorsVIII. B Cell Survival; IX. Summary; References; Chapter 5. CD5 B Cells, a Fetal B Cell Lineage; I. Introduction; II. Background; III. Origins of CD5 B Cells; IV. Model for Generation of CD5 B Cells; V. Properties of Murine CD5 B Cells; VI. Biases in Specificity; VII. Biases in V Gene Usage; VIII. A Homologous Human Population?; IX. Final Considerations and Summary; References; Chapter 6. Human Natural Killer Cells: Origin, Clonality, Specificity, and Receptors; I. Introduction; II. Ontogeny of NK Cells.
- III. Expression of CD3 Genes during NK Cell MaturationIV. Evidence for NK Cell Specificity; V. The Human NK Cell Repertoire; VI. Genetic Analysis of Human NK-Defined Allospecificities; VII. Involvement of Class I Molecules in NK-Specific Functions; VIII. Clonally Distributed Molecules (p58) Involved in Regulation of NK-Mediated Cytolysis; IX. p58 Molecules as Putative Receptors for MHC Class I Molecules in Human NK Cells; X. Human NK Receptors for Class I Molecules Are Composed of p58 Dimers; XI. Effect of p58 Modulation on Cytolytic Activity.